Login / Signup

The real-world tolerability and efficacy of asparaginase in adults aged 40 years and older with Philadelphia-negative acute lymphoblastic leukemia.

Matthew James ReesSimon WuMridula MokoonlallCaroline H K DixChristian E BryantJames D'RozarioAnthony SchwarerAndrew GriggIng Soo Tiong
Published in: Leukemia & lymphoma (2021)
Keyphrases
  • acute lymphoblastic leukemia
  • allogeneic hematopoietic stem cell transplantation
  • open label
  • community dwelling
  • physical activity
  • middle aged
  • double blind
  • placebo controlled
  • clinical trial